Cargando…

Changes in Tumor Stem Cell Markers and Epithelial-Mesenchymal Transition Markers in Nonluminal Breast Cancer after Neoadjuvant Chemotherapy and Their Correlation with Contrast-Enhanced Ultrasound

Nonluminal breast cancer has high early metastasis and treatment resistance, and neoadjuvant chemotherapy (NAC) is needed. The presence of cancer stem cells (CSC) and epithelial-mesenchymal transition (EMT) leads to poor prognosis. This study investigated the changes in CSC markers and EMT markers a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leng, Xiaoling, Huang, Guofu, Zhang, Lianhua, Ding, Jianbing, Ma, Fucheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685800/ https://www.ncbi.nlm.nih.gov/pubmed/33282946 http://dx.doi.org/10.1155/2020/3869538

Ejemplares similares

Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS)
por: Leng, Xiaoling, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition Markers in Breast Cancer and Pathological Responseafter Neoadjuvant Chemotherapy
por: Elzamly, Shaimaa, et al.
Publicado: (2018)

Relationship of shear wave elastography anisotropy with tumor stem cells and epithelial-mesenchymal transition in breast cancer
por: Leng, Xiaoling, et al.
Publicado: (2021)

Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer
por: Feng, Shuqian, et al.
Publicado: (2023)

Regional Contrast-Enhanced Ultrasonography (CEUS) Characteristics of Breast Cancer and Correlation with Microvessel Density (MVD)
por: Leng, Xiaoling, et al.
Publicado: (2017)

Artificial Intelligence Algorithm-Based Ultrasound Image Segmentation Technology in the Diagnosis of Breast Cancer Axillary Lymph Node Metastasis
por: Zhang, Lianhua, et al.
Publicado: (2021)

The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial–Mesenchymal Transition
por: Zapperi, Stefano, et al.
Publicado: (2023)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Analysis of epithelial–mesenchymal transition markers in psoriatic epidermal keratinocytes
por: Man, Xiao-Yong, et al.
Publicado: (2015)

Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases
por: Sacristán-Gómez, Pablo, et al.
Publicado: (2023)

Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer
por: Rix, Anne, et al.
Publicado: (2021)

Implanted markers prior to neoadjuvant chemotherapy: preliminary report
por: Allan for the Dartford Breast Care Team, DM
Publicado: (2000)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Therapeutic Ultrasound Halts Progression of Chronic Kidney Disease In Vivo via the Regulation of Markers Associated with Renal Epithelial–Mesenchymal Transition and Senescence
por: Lin, Chen-Yu, et al.
Publicado: (2022)

Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines
por: Kim, Ji Eun, et al.
Publicado: (2013)

Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors
por: Galván, Jose A, et al.
Publicado: (2014)

Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics
por: Vergara, Daniele, et al.
Publicado: (2016)

Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside
por: Gogola, Samantha, et al.
Publicado: (2023)

The Immunohistochemical Expression of Epithelial–Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer
por: Popiel-Kopaczyk, Aneta, et al.
Publicado: (2023)

Extracellular Acidosis Modulates the Expression of Epithelial-Mesenchymal Transition (EMT) Markers and Adhesion of Epithelial and Tumor Cells
por: Riemann, Anne, et al.
Publicado: (2019)

Epithelial-to-mesenchymal transition markers are differentially expressed in epithelial cancer cell lines after everolimus treatment
por: Gonçalves, Bryan Ôrtero Perez, et al.
Publicado: (2020)

Comparison of the Ultrasound Visibility of Tissue Markers in Metastatic Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Cancer
por: Kim, Ka Eun, et al.
Publicado: (2022)

Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer
por: Peng, Juan, et al.
Publicado: (2021)

Effect of alendronate sodium on the expression of mesenchymal-epithelial transition markers in mice with liver fibrosis
por: BI, WAN-RONG, et al.
Publicado: (2013)

Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma
por: COSTA, Liana Cristina Melo Carneiro, et al.
Publicado: (2015)

Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma
por: NOZATO, MEGUMI, et al.
Publicado: (2012)

ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncology
por: Petrini, Iacopo, et al.
Publicado: (2016)

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer
por: Steinbichler, T. B., et al.
Publicado: (2020)

Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder
por: Nomura, Shunichiro, et al.
Publicado: (2020)

Aberrant Expression of Epithelial-Mesenchymal Transition Markers in Early Gastric Cancer: Clinical Application
por: Joo, Moon Kyung
Publicado: (2019)

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2020)

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
por: Faneyte, I F, et al.
Publicado: (2003)

Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Pectasides, Eirini, et al.
Publicado: (2014)

Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis
por: Qi, Hui-wei, et al.
Publicado: (2014)

TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer
por: Wang, J, et al.
Publicado: (2014)

Extramammary Paget disease of the vulva: immunohistochemical analysis of neoangiogenesis and epithelial-mesenchymal transition markers expression
por: Alessandrini, Lara, et al.
Publicado: (2018)

Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma
por: Song, Jing, et al.
Publicado: (2019)

Markers of epithelial-mesenchymal transition in an experimental breast cancer model induced by organophosphorous pesticides and estrogen
por: Calaf, Gloria M., et al.
Publicado: (2020)

Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition
por: Banias, Laura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ol5o9hmiosqlokd24f9et1fp30